Video

Hanna Gaggin from Massachusetts General Hospital: Type 2 Myocardial Infarction Still a Learning Process

Author(s):

To say that a patient has been diagnosed with myocardial infarction may not paint the full picture of the diagnosis. Recent research has shown there is a second type of the condition which not as much is known about across the spectrum.

To say that a patient has been diagnosed with myocardial infarction may not paint the full picture of the diagnosis. Recent research has shown there is a second type of the condition which not as much is known about across the spectrum.

Hanna K. Gaggin, MD, MPH, from Massachusetts General Hospital discussed this relatively unknown condition and what can be done to make it better understood to improve treatment during the American College of Cardiology's annual meeting in Chicago. Gaggin said that since the causes of the two forms of the condition are different it can mean needing to take different approaches to treatment but there is no definitive approach to help these patients as of yet.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
4 experts are featured in this series.
4 experts are featured in this series.
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
© 2024 MJH Life Sciences

All rights reserved.